excedrin migraine relief (0067-2042)

Drug Facts

Product Profile

Brand Name excedrin migraine relief

Generic Name acetaminophen, aspirin (nsaid), caffeine

Labeler haleon us holdings llc

Dosage Form TABLET, FILM COATED

Routes

ORAL

Active Ingredients

acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1

Manufacturer

Haleon US Holdings LLC

Identifiers & Regulatory

Product NDC 0067-2042

Product ID 0067-2042_27f2895c-750b-4c97-9d33-914f4df59bd2

Product Type HUMAN OTC DRUG

Marketing Category NDA

Application Number NDA020802

Listing Expiration 2026-12-31

Marketing Start 2024-01-01

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs] xanthines [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00672042

Hyphenated Format 0067-2042

Supplemental Identifiers

RxCUI

209468 308297

UNII

362O9ITL9D R16CO5Y76E 3G6A5W338E

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name excedrin migraine relief (source: ndc)

Generic Name acetaminophen, aspirin (nsaid), caffeine (source: ndc)

Application Number NDA020802 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

250 mg/1
65 mg/1

source: ndc

Packaging

1 BOTTLE in 1 CARTON (0067-2042-01) / 24 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (0067-2042-02) / 30 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (0067-2042-03) / 50 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (0067-2042-04) / 100 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (0067-2042-05) / 125 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (0067-2042-06) / 200 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (0067-2042-07) / 250 TABLET, FILM COATED in 1 BOTTLE
300 TABLET, FILM COATED in 1 BOTTLE (0067-2042-08)

source: ndc

Packages (8)

Ingredients (3)

acetaminophen (250 mg/1) aspirin (250 mg/1) caffeine (65 mg/1)

Linked Drug Pages (1)

Excedrin Migraine Relief ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "27f2895c-750b-4c97-9d33-914f4df59bd2", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["dd85f3a7-f4d2-4ea0-a7b6-18ebc0e993d8"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2042-01)  / 24 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2042-01", "marketing_start_date": "20240101"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2042-02)  / 30 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2042-02", "marketing_start_date": "20240101"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2042-03)  / 50 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2042-03", "marketing_start_date": "20240101"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2042-04)  / 100 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2042-04", "marketing_start_date": "20240101"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2042-05)  / 125 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2042-05", "marketing_start_date": "20240101"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2042-06)  / 200 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2042-06", "marketing_start_date": "20240101"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2042-07)  / 250 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2042-07", "marketing_start_date": "20240101"}, {"sample": false, "description": "300 TABLET, FILM COATED in 1 BOTTLE (0067-2042-08)", "package_ndc": "0067-2042-08", "marketing_start_date": "20240101"}], "brand_name": "Excedrin Migraine Relief", "product_id": "0067-2042_27f2895c-750b-4c97-9d33-914f4df59bd2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "0067-2042", "generic_name": "Acetaminophen, Aspirin (NSAID), Caffeine", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Excedrin", "brand_name_suffix": "Migraine Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "NDA020802", "marketing_category": "NDA", "marketing_start_date": "20240101", "listing_expiration_date": "20261231"}